Dynamics and Spatial Distribution of β-Lactamase Expression in Pseudomonas aeruginosa Biofilms

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 4, 2004, Pages 1168-1174

  Bagge, Niels ^a   Hentzer, Morten ^b   Andersen, Jens Bo ^b   Ciofu, Oana ^a   Givskov, Michael ^b   Høiby, Niels ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE AMPC; CEFTAZIDIME; GENE PRODUCT; GREEN FLUORESCENT PROTEIN; IMIPENEM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM COLONY; BIOFILM; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG STABILITY; GENE EXPRESSION REGULATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REPORTER GENE; TRANSCRIPTION INITIATION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; BIOFILMS; DNA, BACTERIAL; ESCHERICHIA COLI; GENES, BACTERIAL; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PLASMIDS; PSEUDOMONAS AERUGINOSA; RNA; TRANSCRIPTION, GENETIC;

EID: 1642502348     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.4.1168-1174.2004     Document Type: Article

References (47)

1. Andersen, J. B., C. Sternberg, L. K. Poulsen, S. P. Bjørn, M. Givskov, and S. Molin. 1998. New unstable variants of green fluorescent protein for studies of transient gene expression in bacteria. Appl. Environ. Microbiol. 64:2240-2246.
2. Anwar, H., J. L. Strap, and J. W. Costerton. 1992. Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob. Agents Chemother. 36:1347-1351.
3. Bagge, N., O. Ciofu, M. Hentzer, J. I. A. Campbell, M. Givskov, and N. Høiby. 2002. Constitutive high expression of chromosomal beta-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD. Antimicrob. Agents Chemother. 46:3406-3411.
4. Baquero, F., M.-C. Negri, M.-I. Morosini, and J. Blázquez. 1998. Antibiotic-selective environments. Clin. Infect. Dis. 27:S5-S11.
5. Christensen, B. B., C. Sternberg, J. B. Andersen, R. J. Palmer, A. T. Nielsen, M. Givskov, and S. Molin. 1999. Molecular tools in physiological studies of microbial biofilms. Methods Enzymol. 310:20-42.
6. Ciofu, O., T. J. Beveridge, J. Kadurugamuwa, J. Walther-Rasmussen, and N. Høiby. 2000. Chromosomal beta-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa. J. Antimicrob. Chemother. 45:9-13.
7. Ciofu, O., V. Fussing, N. Bagge, C. Koch, and N. Høiby. 2001. Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, beta-lactamase activity and RiboPrinting. J. Antimicrob. Chemother. 48:391-396.
8. Ciofu, O., B. Giwercman, S. S. Pedersen, and N. Høiby. 1994. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center. APMIS 102:674-680.
9. Costerton, J. W., Z. Lewandowski, D. DeBeer, D. Caldwell, D. Korber, and G. James. 1994. Biofilms, the customized microniche. J. Bacteriol. 176:2137-2142.
10. Dibdin, G. H., S. J. Assinder, W. W. Nichols, and P. A. Lambert. 1996. Mathematical model of beta-lactam penetration into a biofilm of Pseudomonas aeruginosa while undergoing simultaneous inactivation by released beta-lactamase. J. Antimicrob. Chemother. 38:757-769.
11. Dietz, H., D. Pfeifle, and B. Wiedemann. 1997. The signal molecule for beta-lactamase induction in Enterobacter cloacae is the anhydromuramyl-penta-peptide. Antimicrob. Agents Chemother. 41:2113-2120.
12. Diver, J. M., L. E. Bryan, and P. A. Sokol. 1990. Transformation of Pseudomonas aeruginosa by electroporation. Anal. Biochem. 189:75-79.
13. Frederiksen, B., S. Lanng, C. Koch, and N. Høiby. 1996. Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr. Pulmonol. 21:153-158.
14. Gilbert, P., and M. R. W. Brown. 1998. Biofilms and beta-lactam activity. J. Antimicrob. Chemother. 41:571-578.
15. Giwercman, B., E. T. Jensen, N. Høiby, A. Kharazmi, and J. W. Costerton. 1991. Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm. Antimicrob. Agents Chemother. 35:1008-1010.
16. Giwercman, B., P. A. Lambert, V. T. Rosdahl, G. H. Shand, and N. Høiby. 1990. Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis due to in vivo selection of stable derepressed beta-lactamase producing strains. J. Antimicrob. Chemother. 26:247-259.
17. Giwercman, B., C. Meyer, P. A. Lambert, C. Reinert, and N. Høiby. 1992. High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment. Antimicrob. Agents Chemother. 36:71-76.
18. Hentzer, M., K. Riedel, T. B. Rasmussen, A. Heydorn, J. B. Andersen, M. R. Parsek, S. A. Rice, L. Eberl, S. Molin, N. Høiby, S. Kjelleberg, and M. Givskov. 2002. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 148:87-102.
19. Hentzer, M., G. M. Teitzel, G. J. Baltzer, A. Heydorn, S. Molin, M. Givskov, and M. R. Parsek. 2001. Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J. Bacteriol. 183:5395-5401.
20. Herrero, M., V. de Lorenzo, and K. N. Timmis. 1990. Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in gram-negative bacteria. J. Bacteriol. 172:6557-6567.
21. Høiby, N. 1977. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Acta Pathol. Microbiol. Scand. Suppl. 262:1-96.
22. Høiby, N. 2000. Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosis. Paediatr. Drugs 2:451-463.
23. Høiby, N. 2002. New antimicrobials in the management of cystic fibrosis. J. Antimicrob. Chemother. 49:235-238.
24. Høiby, N., H. K. Johansen, C. Moser, Z. Song, O. Ciofu, and A. Kharazmi. 2001. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microb. Infect. 3:23-35.
25. Holloway, B. W. 1955. Genetic recombination in Pseudomonas aeruginosa. J. Gen. Microbiol. 13:572-581.
26. Jones, R. N. 1998. Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the AmpC enzymes. Diagn. Microbiol. Infect. Dis. 31:461-466.
27. Kessler, B., V. de Lorenzo, and K. N. Timmis. 1992. A general system to integrate lacZ fusions into the chromosomes of gram-negative eubacteria: regulation of the Pm promoter in the TOL plasmid studied with all controlling elements in monocopy. Mol. Gen. Genet. 233:293-301.
28. Koch, C., and N. Høiby. 1993. Pathogenesis of cystic fibrosis. Lancet 341:1065-1069.
29. Lam, J., R. Chan, K. Lam, and J. W. Costerton. 1980. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect. Immun. 28:546-556.
30. Langaee, T. Y., L. Gagnon, and A. Huletsky. 2000. Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpC beta-lactamase expression. Antimicrob. Agents Chemother. 44:583-589.
31. Lautrop, H., N. Høiby, A. Bremmelgaard, and B. Korsager. 1979. Bakteriologiske undersøgelsesmetoder. FADL, Copenhagen, Denmark.
32. Lewis, K. 2001. Riddle of biofilm resistance. Antimicrob. Agents Chemother. 45:999-1007.
33. Nichols, W. W., M. J. Evans, M. P. E. Slack, and H. L. Walmsley. 1989. The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa. J. Gen. Microbiol. 135:1291-1303.
34. Pedersen, S. S., T. Jensen, N. Høiby, C. Koch, and E. W. Flensborg. 1987. Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients. Acta Paediatr. Scand. 76:955-961.
35. Pedersen, S. S., C. Koch, N. Høiby, and K. Rosendal. 1986. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J. Antimicrob. Chemother. 17:505-516.
36. Pedersen, S. S., T. Pressler, T. Jensen, V. T. Rosdahl, M. W. Bentzon, N. Høiby, and C. Koch. 1987. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis. J. Antimicrob. Chemother. 19:101-107.
37. Regelmann, W. E., G. R. Elliott, W. J. Warwick, and C. C. Clawson. 1990. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone. Am. Rev. Respir. Dis. 141:914-921.
38. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
39. Sanders, C. C. 1987. Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics. Annu. Rev. Microbiol. 41:573-593.
40. Singh, P. K., A. L. Schaefer, M. R. Parsek, T. O. Moninger, M. J. Welsh, and E. P. Greenberg. 2000. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407:762-764.
41. Stewart, P. S. 1994. Biofilm accumulation model that predicts antibiotic resistance of Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 38:1052-1058.
42. Stewart, P. S. 1996. Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob. Agents Chemother. 40:2517-2522.
43. Stewart, P. S., and J. W. Costerton. 2001. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138.
44. Szaff, M., N. Høiby, and E. W. Flensborg. 1983. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr. Scand. 72:651-657.
45. Widdel, F., and F. Bak. 1992. The procaryotes. Springer-Verlag, New York, N.Y.
46. Wiedemann, B., H. Dietz, and D. Pfeifle. 1998. Induction of beta-lactamase in Enterobacter cloacae. Clin. Infect. Dis. 27:S42-S47.
47. Yanisch-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119.